Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
apaziquone (EOquin) (formerly EO9, Neoquin)
print preview
bookmark
share with colleague
General Information
Company
Spectrum Pharmaceuticals Inc.
Description
Analog of mitomycin C that is reduced by intracellular reductases into active DNA-damaging moieties
Molecular Target
DNA
Mechanism of Action
Breaks/crosslinks DNA
Latest Stage of Development
Phase III
Indication
Bladder cancer
Partner
Handok Pharmaceutical Co. Ltd.
;
Nippon Kayaku Co. Ltd.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy